Telesis Bio (OTCMKTS:TBIO – Get Free Report) is anticipated to post its results on Tuesday, November 17th. Analysts expect Telesis Bio to post earnings of ($6.39) per share and revenue of $2.53 million for the quarter.
Telesis Bio Price Performance
Shares of TBIO opened at $0.01 on Monday. The company has a market cap of $18,000.00, a PE ratio of -0.00 and a beta of -14.02. The business has a fifty day moving average of $0.01 and a 200 day moving average of $0.03. Telesis Bio has a 52-week low of $0.00 and a 52-week high of $0.15.
About Telesis Bio
Read More
- Five stocks we like better than Telesis Bio
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Telesis Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telesis Bio and related companies with MarketBeat.com's FREE daily email newsletter.
